{
 "instance": {
  "tmdi6k0922.htm tmdi6kex99-2null.htm": {
   "axisCustom": 0,
   "axisStandard": 3,
   "contextCount": 89,
   "dts": {
    "calculationLink": {
     "local": [
      "tmdi-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tmdi-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tmdi6k0922.htm",
      "tmdi6kex99-2null.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tmdi-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tmdi-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tmdi-20220930.xsd",
      "reference-2009-12-16.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd"
     ]
    }
   },
   "elementCount": 290,
   "entityCount": 1,
   "hidden": {
    "http://www.titanmedicalinc.com/20220930": 25,
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 18,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 48
   },
   "keyCustom": 82,
   "keyStandard": 114,
   "memberCustom": 23,
   "memberStandard": 2,
   "nsprefix": "tmdi",
   "nsuri": "http://www.titanmedicalinc.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "tmdi6k0922.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "tmdi6k0922.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - DEFERRED REVENUE",
     "role": "http://www.titanmedicalinc.com/role/DEFERREDREVENUE",
     "shortName": "DEFERRED REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - WARRANT DERIVATIVE LIABILITY",
     "role": "http://www.titanmedicalinc.com/role/WARRANTDERIVATIVELIABILITY",
     "shortName": "WARRANT DERIVATIVE LIABILITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - SHARE CAPITAL",
     "role": "http://www.titanmedicalinc.com/role/SHARECAPITAL",
     "shortName": "SHARE CAPITAL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:DisclosureOfContributedSurplusWarrantReserveExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - CONTRIBUTED SURPLUS-WARRANT RESERVE",
     "role": "http://www.titanmedicalinc.com/role/CONTRIBUTEDSURPLUSWARRANTRESERVE",
     "shortName": "CONTRIBUTED SURPLUS-WARRANT RESERVE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:DisclosureOfContributedSurplusWarrantReserveExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - DEPRECIATION AND AMORTIZATION",
     "role": "http://www.titanmedicalinc.com/role/DEPRECIATIONANDAMORTIZATION",
     "shortName": "DEPRECIATION AND AMORTIZATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - SHARE-BASED COMPENSATION",
     "role": "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - LOSS PER SHARE",
     "role": "http://www.titanmedicalinc.com/role/LOSSPERSHARE",
     "shortName": "LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - FINANCIAL RISK MANAGEMENT",
     "role": "http://www.titanmedicalinc.com/role/FINANCIALRISKMANAGEMENT",
     "shortName": "FINANCIAL RISK MANAGEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - CAPITAL MANAGEMENT",
     "role": "http://www.titanmedicalinc.com/role/CAPITALMANAGEMENT",
     "shortName": "CAPITAL MANAGEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - COMMITMENTS",
     "role": "http://www.titanmedicalinc.com/role/COMMITMENTS",
     "shortName": "COMMITMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Condensed Interim Consolidated Statements of Financial Position (Unaudited)",
     "role": "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet",
     "shortName": "Condensed Interim Consolidated Statements of Financial Position (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://www.titanmedicalinc.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Tables)",
     "role": "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESTables",
     "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:DisclosureOfDetailedInformationAboutWarrantLiabilityExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - WARRANT DERIVATIVE LIABILITY (Tables)",
     "role": "http://www.titanmedicalinc.com/role/WARRANTDERIVATIVELIABILITYTables",
     "shortName": "WARRANT DERIVATIVE LIABILITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:DisclosureOfDetailedInformationAboutWarrantLiabilityExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - CONTRIBUTED SURPLUS-WARRANT RESERVE (Tables)",
     "role": "http://www.titanmedicalinc.com/role/CONTRIBUTEDSURPLUSWARRANTRESERVETables",
     "shortName": "CONTRIBUTED SURPLUS-WARRANT RESERVE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:DisclosureOfDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - DEPRECIATION AND AMORTIZATION (Tables)",
     "role": "http://www.titanmedicalinc.com/role/DEPRECIATIONANDAMORTIZATIONTables",
     "shortName": "DEPRECIATION AND AMORTIZATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:DisclosureOfDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - LOSS PER SHARE (Tables)",
     "role": "http://www.titanmedicalinc.com/role/LOSSPERSHARETables",
     "shortName": "LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "tmdi:RetainedEarningAccumulatedDeficit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - NATURE OF BUSINESS (Details)",
     "role": "http://www.titanmedicalinc.com/role/NATUREOFBUSINESSDetails",
     "shortName": "NATURE OF BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "tmdi:RetainedEarningAccumulatedDeficit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:LeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Details)",
     "role": "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESDetails",
     "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:LeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Details) - Summary of right-of-use assets",
     "role": "http://www.titanmedicalinc.com/role/SummaryofrightofuseassetsTable",
     "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Details) - Summary of right-of-use assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c4",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Condensed Interim Consolidated Statements of Net and Comprehensive Loss (Unaudited)",
     "role": "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement",
     "shortName": "Condensed Interim Consolidated Statements of Net and Comprehensive Loss (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c4",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Details) - Summary of right-of-use liabilities",
     "role": "http://www.titanmedicalinc.com/role/SummaryofrightofuseliabilitiesTable",
     "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITIES (Details) - Summary of right-of-use liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c31",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "tmdi:TotalCommitment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - DEFERRED REVENUE (Details)",
     "role": "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails",
     "shortName": "DEFERRED REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c31",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "tmdi:TotalCommitment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDetailedInformationAboutWarrantLiabilityExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "tmdi:NumberOfWarrantsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - WARRANT DERIVATIVE LIABILITY (Details) - Summary of warrant derivative",
     "role": "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable",
     "shortName": "WARRANT DERIVATIVE LIABILITY (Details) - Summary of warrant derivative",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDetailedInformationAboutWarrantLiabilityExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "tmdi:NumberOfWarrantsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDetailedInformationAboutWarrantsOutstandingExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "tmdi:NumberOfWarrantsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - WARRANT DERIVATIVE LIABILITY (Details) - Summary of derivative warrants outstanding",
     "role": "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable",
     "shortName": "WARRANT DERIVATIVE LIABILITY (Details) - Summary of derivative warrants outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDetailedInformationAboutWarrantsOutstandingExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "tmdi:NumberOfWarrantsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - SHARE CAPITAL (Details)",
     "role": "http://www.titanmedicalinc.com/role/SHARECAPITALDetails",
     "shortName": "SHARE CAPITAL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:EquityWarrantsExpire",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - CONTRIBUTED SURPLUS-WARRANT RESERVE (Details)",
     "role": "http://www.titanmedicalinc.com/role/CONTRIBUTEDSURPLUSWARRANTRESERVEDetails",
     "shortName": "CONTRIBUTED SURPLUS-WARRANT RESERVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "tmdi:EquityWarrantsExpire",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "tmdi:NumberIssuedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - CONTRIBUTED SURPLUS-WARRANT RESERVE (Details) - Summary of Equity Warrants Were Outstanding",
     "role": "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable",
     "shortName": "CONTRIBUTED SURPLUS-WARRANT RESERVE (Details) - Summary of Equity Warrants Were Outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "tmdi:NumberIssuedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDepreciationAndAmortization",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - DEPRECIATION AND AMORTIZATION (Details) - Schedule of depreciation and amortization expense",
     "role": "http://www.titanmedicalinc.com/role/ScheduleofdepreciationandamortizationexpenseTable",
     "shortName": "DEPRECIATION AND AMORTIZATION (Details) - Schedule of depreciation and amortization expense",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDepreciationAndAmortization",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "tmdi:IssuedAndOutstandingPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - SHARE-BASED COMPENSATION (Details)",
     "role": "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATIONDetails",
     "shortName": "SHARE-BASED COMPENSATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "tmdi:IssuedAndOutstandingPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c61",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans",
     "role": "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable",
     "shortName": "SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c61",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c3",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DilutedEarningsLossPerShare",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Condensed Interim Consolidated Statements of Net and Comprehensive Loss (Unaudited) (Parentheticals)",
     "role": "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement_Parentheticals",
     "shortName": "Condensed Interim Consolidated Statements of Net and Comprehensive Loss (Unaudited) (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c62",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "tmdi:PercentageOfSharebasedCompensationAvailableForIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans (Parentheticals)",
     "role": "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable_Parentheticals",
     "shortName": "SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c62",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "tmdi:PercentageOfSharebasedCompensationAvailableForIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - SHARE-BASED COMPENSATION (Details) - Summary of granted stock options to acquire common stock",
     "role": "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable",
     "shortName": "SHARE-BASED COMPENSATION (Details) - Summary of granted stock options to acquire common stock",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - SHARE-BASED COMPENSATION (Details) - Summary of granted restricted share units",
     "role": "http://www.titanmedicalinc.com/role/SummaryofgrantedrestrictedshareunitsTable",
     "shortName": "SHARE-BASED COMPENSATION (Details) - Summary of granted restricted share units",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDetailedInformationAboutStockBasedCompensationExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - SHARE-BASED COMPENSATION (Details) - Summary of stock-based compensation expense",
     "role": "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable",
     "shortName": "SHARE-BASED COMPENSATION (Details) - Summary of stock-based compensation expense",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tmdi:DisclosureOfDetailedInformationAboutStockBasedCompensationExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - LOSS PER SHARE (Details) - Summary of basic and fully diluted number of shares",
     "role": "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable",
     "shortName": "LOSS PER SHARE (Details) - Summary of basic and fully diluted number of shares",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - FINANCIAL RISK MANAGEMENT (Details)",
     "role": "http://www.titanmedicalinc.com/role/FINANCIALRISKMANAGEMENTDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - CAPITAL MANAGEMENT (Details)",
     "role": "http://www.titanmedicalinc.com/role/CAPITALMANAGEMENTDetails",
     "shortName": "CAPITAL MANAGEMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RetentionPayables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - COMMITMENTS (Details)",
     "role": "http://www.titanmedicalinc.com/role/COMMITMENTSDetails",
     "shortName": "COMMITMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RetentionPayables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Condensed Interim Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow",
     "shortName": "Condensed Interim Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:DepreciationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Condensed Interim Consolidated Statements of Shareholders\u2019 Equity (Unaudited)",
     "role": "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3",
     "shortName": "Condensed Interim Consolidated Statements of Shareholders\u2019 Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "006 - Disclosure - NATURE OF BUSINESS",
     "role": "http://www.titanmedicalinc.com/role/NATUREOFBUSINESS",
     "shortName": "NATURE OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - SIGNIFICANT ACCOUNTIING POLICIES",
     "role": "http://www.titanmedicalinc.com/role/SIGNIFICANTACCOUNTIINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTIING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITIES",
     "role": "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIES",
     "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "tmdi6kex99-2null.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 25,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions to right-of-use assets",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsToRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "terseLabel": "Weighted average number of common shares outstanding for basic EPS",
        "verboseLabel": "Weighted average number of common shares outstanding for diluted EPS"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade accounts receivable",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in deferred income including contract liabilities",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Items not involving current cash flows:"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r19",
      "r71",
      "r72",
      "r73",
      "r101",
      "r104"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r43",
      "r44"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic and fully diluted loss per share (in Dollars per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_Cash": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/FINANCIALRISKMANAGEMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r17",
      "r57",
      "r69"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of the period",
        "periodStartLabel": "Cash and cash equivalents, beginning of the period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet",
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r48",
      "r58"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r48",
      "r58"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Cash used in investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r48",
      "r58"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Cash used in operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails",
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share capital [member]",
        "terseLabel": "Share Capital [Member]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r4",
      "r30",
      "r60",
      "r62",
      "r63",
      "r67"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "terseLabel": "Net loss and comprehensive loss",
        "totalLabel": "Net and comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement",
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current accrued expenses and other current liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r21",
      "r63",
      "r64"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "TOTAL CURRENT ASSETS"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Current portion of lease liabilities"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r22",
      "r63",
      "r66"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "TOTAL CURRENT LIABILITIES"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "terseLabel": "Prepaid expenses, deposits and receivables"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r18",
      "r20",
      "r36"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r1",
      "r3",
      "r34",
      "r70",
      "r100",
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation and amortisation expense",
        "terseLabel": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortisationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ScheduleofdepreciationandamortizationexpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationExpense": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r37",
      "r39"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "terseLabel": "Depreciation of PPE"
       }
      }
     },
     "localname": "DepreciationPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ScheduleofdepreciationandamortizationexpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, right-of-use assets",
        "terseLabel": "Depreciation of ROU assets"
       }
      }
     },
     "localname": "DepreciationRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ScheduleofdepreciationandamortizationexpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r43",
      "r44"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted loss per share",
        "verboseLabel": "Basic and fully diluted loss per share (in Dollars per share)"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "terseLabel": "Estimates, assumptions, and judgments"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of commitments [text block]",
        "terseLabel": "COMMITMENTS"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/COMMITMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDepreciationAndAmortisationExpenseExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of depreciation and amortisation expense. [Refer: Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of depreciation and amortisation expense [text block]",
        "terseLabel": "DEPRECIATION AND AMORTIZATION"
       }
      }
     },
     "localname": "DisclosureOfDepreciationAndAmortisationExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEPRECIATIONANDAMORTIZATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [text block]",
        "terseLabel": "LOSS PER SHARE"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/LOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expenses by nature [text block]",
        "terseLabel": "NATURE OF BUSINESS"
       }
      }
     },
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/NATUREOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [text block]",
        "terseLabel": "WARRANT DERIVATIVE LIABILITY"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/WARRANTDERIVATIVELIABILITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial risk management [text block]",
        "terseLabel": "FINANCIAL RISK MANAGEMENT"
       }
      }
     },
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/FINANCIALRISKMANAGEMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "SIGNIFICANT ACCOUNTIING POLICIES"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SIGNIFICANTACCOUNTIINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIssuedCapitalExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of issued capital [text block]",
        "terseLabel": "CAPITAL MANAGEMENT"
       }
      }
     },
     "localname": "DisclosureOfIssuedCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/CAPITALMANAGEMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of leases [text block]",
        "terseLabel": "RIGHT-OF-USE ASSETS AND LEASE LIABILITIES"
       }
      }
     },
     "localname": "DisclosureOfLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [text block]",
        "terseLabel": "Summary of right-of-use liabilities"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]",
        "terseLabel": "Summary of granted restricted share units"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]",
        "terseLabel": "Summary of granted stock options to acquire common stock"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Summary of right-of-use assets"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the range of exercise prices for outstanding share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of range of exercise prices of outstanding share options [text block]",
        "terseLabel": "Summary of Equity Warrants Were Outstanding"
       }
      }
     },
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/CONTRIBUTEDSURPLUSWARRANTRESERVETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of revenue [text block]",
        "terseLabel": "DEFERRED REVENUE"
       }
      }
     },
     "localname": "DisclosureOfRevenueExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "SHARE CAPITAL"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHARECAPITAL"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share-based payment arrangements [text block]",
        "terseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [text block]",
        "terseLabel": "Summary of share-based compensation plans"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Earnings per share [text block]",
        "terseLabel": "Summary of basic and fully diluted number of shares"
       }
      }
     },
     "localname": "EarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/LOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails",
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r19",
      "r24",
      "r59",
      "r61",
      "r71",
      "r72",
      "r73"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet",
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [abstract]",
        "terseLabel": "SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ExpenseByNature": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Expenses, by nature",
        "totalLabel": "Total expenses"
       }
      }
     },
     "localname": "ExpenseByNature",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseByNatureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses by nature [abstract]",
        "terseLabel": "Expenses"
       }
      }
     },
     "localname": "ExpenseByNatureAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The explanation of the measurement basis (or bases) used in preparing the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Explanation of measurement bases used in preparing financial statements [text block]",
        "terseLabel": "Basis of measurement"
       }
      }
     },
     "localname": "ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "terseLabel": "Finance expense"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "negatedLabel": "Finance income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities",
        "periodEndLabel": "Fair Value of Warrant Derivative, Ending",
        "periodStartLabel": "Fair Value of Warrant Derivative, Beginning"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ForeignExchangeLoss": {
     "auth_ref": [
      "r13",
      "r40"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gross loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Foreign exchange loss",
        "terseLabel": "Foreign exchange (gain) loss"
       }
      }
     },
     "localname": "ForeignExchangeLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "totalLabel": "(Decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of ordinary shares issued",
        "terseLabel": "Issuance of common shares (in Shares)"
       }
      }
     },
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Stock options exercised"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r6"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "terseLabel": "Interest expense on lease liabilities"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "periodEndLabel": "Balance, September 30",
        "periodStartLabel": "Balance, January 1"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r19",
      "r71",
      "r72",
      "r73",
      "r101",
      "r105"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r21",
      "r63",
      "r65"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "TOTAL NON-CURRENT ASSETS"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "NON-CURRENT ASSETS"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "terseLabel": "NON-CURRENT LIABILITIES"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedrestrictedshareunitsTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments outstanding in share-based payment arrangement",
        "negatedLabel": "RSU outstanding, September 30, 2022",
        "periodEndLabel": "Balance, September 30",
        "periodStartLabel": "Balance at Jan 1"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedrestrictedshareunitsTable",
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "auth_ref": [
      "r85",
      "r90",
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options outstanding in share-based payment arrangement",
        "negatedLabel": "Stock options outstanding, September 30, 2022",
        "periodEndLabel": "Stock Options, Balance, June 30",
        "periodStartLabel": "Stock Options, Balance, January 1"
       }
      }
     },
     "localname": "NumberOfOutstandingShareOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable",
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "negatedLabel": "Stock Options, Exercised"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options expired in share-based payment arrangement",
        "negatedLabel": "Stock Options, Expired"
       }
      }
     },
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options forfeited in share-based payment arrangement",
        "negatedLabel": "Stock Options, Forfeited"
       }
      }
     },
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options granted in share-based payment arrangement",
        "terseLabel": "Stock Options, Granted"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares outstanding",
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)",
        "terseLabel": "Common shares outstanding, September 30, 2022"
       }
      }
     },
     "localname": "NumberOfSharesOutstanding",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3",
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OtherCashAndCashEquivalents": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents and shareholders\u2019 equity amount"
       }
      }
     },
     "localname": "OtherCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/CAPITALMANAGEMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "OtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "negatedTotalLabel": "Total other income"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Repayment of lease liabilities"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Presentation of leases for lessee [Abstract]"
       }
      }
     },
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Proceeds from issuance of common shares"
       }
      }
     },
     "localname": "ProceedsFromIssuingShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r29",
      "r54",
      "r60",
      "r62",
      "r63",
      "r101",
      "r103",
      "r110",
      "r111"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Net loss and comprehensive loss",
        "verboseLabel": "Net loss (in Dollars)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow",
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r33",
      "r42"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Net loss from operations"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r15",
      "r38"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of intangible assets, classified as investing activities",
        "negatedLabel": "Purchase of patents"
       }
      }
     },
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfMiningAssets": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of mining assets. [Refer: Mining assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of mining assets",
        "terseLabel": "Purchase of medtronic"
       }
      }
     },
     "localname": "PurchaseOfMiningAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarnings": {
     "auth_ref": [
      "r24",
      "r35"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "terseLabel": "Deficit"
       }
      }
     },
     "localname": "RetainedEarnings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r8",
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetentionPayables": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of payment that is withheld by the entity, pending the fulfilment of a condition."
       }
      },
      "en-us": {
       "role": {
        "label": "Retention payables",
        "terseLabel": "Committed payment"
       }
      }
     },
     "localname": "RetentionPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/COMMITMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r1",
      "r2",
      "r31",
      "r63",
      "r68",
      "r96",
      "r99",
      "r102",
      "r107",
      "r108",
      "r109"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Balance, September 30",
        "periodStartLabel": "Balance, January 1",
        "terseLabel": "Right-of-use assets, net"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet",
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremium": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium",
        "terseLabel": "Contributed surplus"
       }
      }
     },
     "localname": "SharePremium",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable",
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable",
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "auth_ref": [
      "r16",
      "r23"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable",
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable",
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable",
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable_Parentheticals",
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_WarrantLiability": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of warrant liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Warrant liability",
        "terseLabel": "Warrant derivative liability"
       }
      }
     },
     "localname": "WarrantLiability",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement",
        "terseLabel": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options expired in share-based payment arrangement",
        "terseLabel": "Weighted Average Exercise Price, Expired"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement",
        "terseLabel": "Weighted Average Exercise Price, Forfeited"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement",
        "terseLabel": "Weighted Average Exercise Price, Granted"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r85",
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Weighted Average Exercise Price, Balance, June 30",
        "periodStartLabel": "Weighted Average Exercise Price, Balance, January 1"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedstockoptionstoacquirecommonstockTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16",
        "terseLabel": "Incremental borrowing rate"
       }
      }
     },
     "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tmdi_AdditionalLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional lease term.",
        "label": "Additional Lease Term",
        "terseLabel": "Additional lease term"
       }
      }
     },
     "localname": "AdditionalLeaseTerm",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "tmdi_AdditionsToRightofuseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of additions to right-of-use liabilities.",
        "label": "Additions To Rightofuse Liabilities",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsToRightofuseLiabilities",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_AdjustmentForDilutedSecurities1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for diluted securities shares.",
        "label": "Adjustment For Diluted Securities1",
        "terseLabel": "Adjustment for diluted securities"
       }
      }
     },
     "localname": "AdjustmentForDilutedSecurities1",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_AdjustmentsForDecreaseIncreaseInTradeAccountReceivablePrepaidExpensesAndDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for decrease increase in trade account receivable prepaid expenses and deposits.",
        "label": "Adjustments For Decrease Increase In Trade Account Receivable Prepaid Expenses And Deposits",
        "terseLabel": "Prepaid expenses and deposits"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivablePrepaidExpensesAndDeposits",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_AdjustmentsForIncreaseDecreaseInTradePayablesAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for increase decrease in trade payables and accrued liabilities.",
        "label": "Adjustments For Increase Decrease In Trade Payables And Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradePayablesAndAccruedLiabilities",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_AmortizationExpenseRightofuseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of amortization of right-of-use assets.",
        "label": "Amortization Expense Rightofuse Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationExpenseRightofuseAssets",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_AspireCapitalFundLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aspire Capital Fund LLCMember",
        "terseLabel": "Aspire Capital Fund, LLC [Member]"
       }
      }
     },
     "localname": "AspireCapitalFundLLCMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_BasisOfConsolidationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Basis Of Consolidation Text Block",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "BasisOfConsolidationTextBlock",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tmdi_CONTRIBUTEDSURPLUSWARRANTRESERVEDetailsSummaryofEquityWarrantsWereOutstandingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONTRIBUTED SURPLUS-WARRANT RESERVE (Details) - Summary of Equity Warrants Were Outstanding [Line Items]"
       }
      }
     },
     "localname": "CONTRIBUTEDSURPLUSWARRANTRESERVEDetailsSummaryofEquityWarrantsWereOutstandingLineItems",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_CONTRIBUTEDSURPLUSWARRANTRESERVEDetailsSummaryofEquityWarrantsWereOutstandingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONTRIBUTED SURPLUS-WARRANT RESERVE (Details) - Summary of Equity Warrants Were Outstanding [Table]"
       }
      }
     },
     "localname": "CONTRIBUTEDSURPLUSWARRANTRESERVEDetailsSummaryofEquityWarrantsWereOutstandingTable",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_ChangesInNonCashWorkingCapitalBalancesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes In Non Cash Working Capital Balances Abstract",
        "terseLabel": "Changes in non-cash working capital balances"
       }
      }
     },
     "localname": "ChangesInNonCashWorkingCapitalBalancesAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_ClosingBidPrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of closing bid price means the price per share in the last reported trade of the common stock on a primary market or on the exchange which the common stock is then listed as quoted by bloomberg.",
        "label": "Closing Bid Price",
        "terseLabel": "Bid price"
       }
      }
     },
     "localname": "ClosingBidPrice",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/FINANCIALRISKMANAGEMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_CommonSharesWarrantSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of common shares, warrants securities.",
        "label": "Common Shares Warrant Securities",
        "terseLabel": "Common shares, warrants securities"
       }
      }
     },
     "localname": "CommonSharesWarrantSecurities",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/CAPITALMANAGEMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_CondensedInterimConsolidatedStatementsOfShareholdersEquityUnauditedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Interim Consolidated Statements Of Shareholders Equity Unaudited Abstract"
       }
      }
     },
     "localname": "CondensedInterimConsolidatedStatementsOfShareholdersEquityUnauditedAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_ContributedSurplusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contributed Surplus [Member]",
        "label": "Contributed Surplus Member",
        "terseLabel": "Contributed Surplus [Member]"
       }
      }
     },
     "localname": "ContributedSurplusMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_ContributedSurplusWarrantReserveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contributed Surplus- Warrant Reserve [Member]",
        "label": "Contributed Surplus Warrant Reserve Member",
        "terseLabel": "Contributed Surplus \u2013 Warrant Reserve [Member]"
       }
      }
     },
     "localname": "ContributedSurplusWarrantReserveMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_DEFERREDREVENUEDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DEFERRED REVENUE (Details) [Line Items]"
       }
      }
     },
     "localname": "DEFERREDREVENUEDetailsLineItems",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_DEFERREDREVENUEDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DEFERRED REVENUE (Details) [Table]"
       }
      }
     },
     "localname": "DEFERREDREVENUEDetailsTable",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_DeferredRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenues",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenues",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denominator Abstract",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_DerivativeWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants are a derivative that give the right, but not the obligation, to buy or sell a security\u2014most commonly an equity\u2014at a certain price before expiration.",
        "label": "Derivative Warrants Exercised",
        "terseLabel": "Derivative warrants exercised"
       }
      }
     },
     "localname": "DerivativeWarrantsExercised",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_DerivativeWarrantsExercisedFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative warrants exercised - fair value adjustment.",
        "label": "Derivative Warrants Exercised Fair Value Adjustment",
        "terseLabel": "Derivative warrants exercised - fair value adjustment"
       }
      }
     },
     "localname": "DerivativeWarrantsExercisedFairValueAdjustment",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_DerivativeWarrantsExercisedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative warrants exercised, shares.",
        "label": "Derivative Warrants Exercised Shares",
        "terseLabel": "Derivative warrants exercised (in Shares)"
       }
      }
     },
     "localname": "DerivativeWarrantsExercisedShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_DescriptionOfExpiryDateOfWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of expiry date of warrants during the period.",
        "label": "Description Of Expiry Date Of Warrant",
        "terseLabel": "Expiry Date"
       }
      }
     },
     "localname": "DescriptionOfExpiryDateOfWarrant",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_DescriptionOfExpiryDateOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of expiry date of warrants during the period.",
        "label": "Description Of Expiry Date Of Warrants",
        "terseLabel": "Expiry Date"
       }
      }
     },
     "localname": "DescriptionOfExpiryDateOfWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfCommitmentsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfContributedSurplusWarrantReserveExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for contributed surplus warrant reserve.",
        "label": "Disclosure Of Contributed Surplus Warrant Reserve Explanatory",
        "terseLabel": "CONTRIBUTED SURPLUS-WARRANT RESERVE"
       }
      }
     },
     "localname": "DisclosureOfContributedSurplusWarrantReserveExplanatory",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/CONTRIBUTEDSURPLUSWARRANTRESERVE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tmdi_DisclosureOfContributedSurplusWarrantReserveExplanatoryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributed Surplus [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfContributedSurplusWarrantReserveExplanatoryAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfDepreciationAndAmortisationExpenseTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of depreciation and amortization expense [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfDepreciationAndAmortisationExpenseTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfDepreciationAndAmortization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of depreciation and amortization.",
        "label": "Disclosure Of Depreciation And Amortization",
        "terseLabel": "Schedule of depreciation and amortization expense"
       }
      }
     },
     "localname": "DisclosureOfDepreciationAndAmortization",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEPRECIATIONANDAMORTIZATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tmdi_DisclosureOfDetailedInformationAboutStockBasedCompensationExpenseExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about stock-based compensation expense.",
        "label": "Disclosure Of Detailed Information About Stock Based Compensation Expense Explanatory",
        "terseLabel": "Summary of stock-based compensation expense"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutStockBasedCompensationExpenseExplanatory",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tmdi_DisclosureOfDetailedInformationAboutWarrantLiabilityExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about warrant liability.",
        "label": "Disclosure Of Detailed Information About Warrant Liability Explanatory",
        "terseLabel": "Summary of warrant derivative"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutWarrantLiabilityExplanatory",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/WARRANTDERIVATIVELIABILITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tmdi_DisclosureOfDetailedInformationAboutWarrantsOutstandingExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about warrants outstanding.",
        "label": "Disclosure Of Detailed Information About Warrants Outstanding Explanatory",
        "terseLabel": "Summary of derivative warrants outstanding"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutWarrantsOutstandingExplanatory",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/WARRANTDERIVATIVELIABILITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "tmdi_DisclosureOfEarningsPerShareTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfExpensesByNatureTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Business [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfExpensesByNatureTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfFinancialLiabilitiesTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Derivative Liability [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfFinancialRiskManagementTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfFinancialRiskManagementTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Management [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfRevenueTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfRevenueTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfShareBasedPaymentArrangementsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfShareBasedPaymentArrangementsTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_EquityWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity warrants exercised.",
        "label": "Equity Warrants Exercised",
        "terseLabel": "Equity warrants exercised"
       }
      }
     },
     "localname": "EquityWarrantsExercised",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_EquityWarrantsExercisedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity warrants exercised, shares.",
        "label": "Equity Warrants Exercised Shares",
        "terseLabel": "Equity warrants exercised (in Shares)"
       }
      }
     },
     "localname": "EquityWarrantsExercisedShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_EquityWarrantsExpire": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of equity warrant.",
        "label": "Equity Warrants Expire",
        "terseLabel": "Equity warrants expire"
       }
      }
     },
     "localname": "EquityWarrantsExpire",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/CONTRIBUTEDSURPLUSWARRANTRESERVEDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "tmdi_EquityWarrantsExpired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity warrants expired.",
        "label": "Equity Warrants Expired",
        "terseLabel": "Equity warrants expired"
       }
      }
     },
     "localname": "EquityWarrantsExpired",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_ExerciseOfDerivativeWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of exercise of derivative warrants.",
        "label": "Exercise Of Derivative Warrants",
        "terseLabel": "Exercise of Derivative warrants"
       }
      }
     },
     "localname": "ExerciseOfDerivativeWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_ExerciseOfEquityWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of exercise of equity warrants.",
        "label": "Exercise Of Equity Warrants",
        "terseLabel": "Exercise of Equity warrants"
       }
      }
     },
     "localname": "ExerciseOfEquityWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_ExercisePriceOfOutstandingWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exercise price of outstanding warrants.",
        "label": "Exercise Price Of Outstanding Warrants",
        "terseLabel": "Exercise Price (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePriceOfOutstandingWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "tmdi_ExercisePriceOfOutstandingWarrants2019": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exercise price of outstanding warrants.",
        "label": "Exercise Price Of Outstanding Warrants2019",
        "terseLabel": "Exercise Price (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePriceOfOutstandingWarrants2019",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "tmdi_ExpiredinShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement.",
        "label": "Expiredin Shares",
        "terseLabel": "Expired (in Shares)"
       }
      }
     },
     "localname": "ExpiredinShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedrestrictedshareunitsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_FairValueOfWarrantDerivativeChangeInFairValueValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value derivative warrant liability, change in fair value.",
        "label": "Fair Value Of Warrant Derivative Change In Fair Value Value",
        "terseLabel": "Fair Value of Warrant Derivative, Change in fair value"
       }
      }
     },
     "localname": "FairValueOfWarrantDerivativeChangeInFairValueValue",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_FairValueOfWarrantDerivativeExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fair value of warrant derivative exercised.",
        "label": "Fair Value Of Warrant Derivative Exercised",
        "terseLabel": "Fair Value of Warrant Derivative, Exercised"
       }
      }
     },
     "localname": "FairValueOfWarrantDerivativeExercised",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_FairValueOfWarrantDerivativeExpired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial liabilities warrants exercised.",
        "label": "Fair Value Of Warrant Derivative Expired",
        "terseLabel": "Fair Value of Warrant Derivative, Expired"
       }
      }
     },
     "localname": "FairValueOfWarrantDerivativeExpired",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_February2021EquityOfferingNetOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of equity offering, net of issuance costs.",
        "label": "February2021 Equity Offering Net Of Issuance Costs",
        "terseLabel": "February 2021 Equity Offering, net of issuance costs"
       }
      }
     },
     "localname": "February2021EquityOfferingNetOfIssuanceCosts",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_February2021EquityOfferingNetOfIssuanceCostsShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 equity offering, net of issuance costs, shares.",
        "label": "February2021 Equity Offering Net Of Issuance Costs Share",
        "terseLabel": "February 2021 equity offering, net of issuance costs (in Shares)"
       }
      }
     },
     "localname": "February2021EquityOfferingNetOfIssuanceCostsShare",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_February2021EquityOfferingNetOfIssuanceCostsvalue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 equity offering, net of issuance costs.",
        "label": "February2021 Equity Offering Net Of Issuance Costsvalue",
        "terseLabel": "February 2021 equity offering, net of issuance costs"
       }
      }
     },
     "localname": "February2021EquityOfferingNetOfIssuanceCostsvalue",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_February2021EquityOfferingbrokerWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 equity offering-broker warrants.",
        "label": "February2021 Equity Offeringbroker Warrants",
        "terseLabel": "February 2021 equity offering, broker warrants"
       }
      }
     },
     "localname": "February2021EquityOfferingbrokerWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_GAStockOptionsRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GAStock Options RSUs Member",
        "terseLabel": "Total G&amp;A - Stock options &amp; RSUs [Member]"
       }
      }
     },
     "localname": "GAStockOptionsRSUsMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_GainLossOnChangeInFairValueOfWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of (gain) loss on change in fair value of warrants.",
        "label": "Gain Loss On Change In Fair Value Of Warrants",
        "negatedLabel": "Gain on change in fair value of warrants"
       }
      }
     },
     "localname": "GainLossOnChangeInFairValueOfWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_GainLossOnChangeOfFairValueOfWarrantLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain loss on change of fair value of warrant liability.",
        "label": "Gain Loss On Change Of Fair Value Of Warrant Liability",
        "negatedLabel": "Gain on fair value of warrant"
       }
      }
     },
     "localname": "GainLossOnChangeOfFairValueOfWarrantLiability",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_GeneralAndAdministrativeAmortizationOfPatentRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and administrative amortization of patent rights.",
        "label": "General And Administrative Amortization Of Patent Rights",
        "terseLabel": "G&amp;A - Amortization of patent rights"
       }
      }
     },
     "localname": "GeneralAndAdministrativeAmortizationOfPatentRights",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ScheduleofdepreciationandamortizationexpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_IncrementalBorrowingRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental borrowing rate.",
        "label": "Incremental Borrowing Rate",
        "terseLabel": "Incremental borrowing rate (IBR)"
       }
      }
     },
     "localname": "IncrementalBorrowingRate",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tmdi_IntellectualPropertyPatentRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intellectual property patent rights.",
        "label": "Intellectual Property Patent Rights",
        "terseLabel": "Patent rights, net"
       }
      }
     },
     "localname": "IntellectualPropertyPatentRights",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_InterestExpensesOnLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest expense payable on lease liabilities.",
        "label": "Interest Expenses On Lease Liabilities",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpensesOnLeaseLiabilities",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_IssuanceDate1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date1 Member",
        "terseLabel": "27-Mar-20 [Member]"
       }
      }
     },
     "localname": "IssuanceDate1Member",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuanceDate2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date2 Member",
        "terseLabel": "06-May-20 [Member]"
       }
      }
     },
     "localname": "IssuanceDate2Member",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuanceDate3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date3 Member",
        "terseLabel": "10-Jun-20 [Member]"
       }
      }
     },
     "localname": "IssuanceDate3Member",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuanceDate4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date4 Member",
        "terseLabel": "26-Jan-21 [Member]"
       }
      }
     },
     "localname": "IssuanceDate4Member",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuanceDate5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date5 Member",
        "terseLabel": "26-Jan-21 One [Member]"
       }
      }
     },
     "localname": "IssuanceDate5Member",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuanceDate6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date6 Member",
        "terseLabel": "24-Feb-21 [Member]"
       }
      }
     },
     "localname": "IssuanceDate6Member",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuanceDate7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date7 Member",
        "terseLabel": "24-Feb-21 One [Member]"
       }
      }
     },
     "localname": "IssuanceDate7Member",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuanceOfCommonShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common shares.",
        "label": "Issuance Of Common Shares",
        "terseLabel": "Issuance of common shares"
       }
      }
     },
     "localname": "IssuanceOfCommonShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_IssueDateFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Date Five Member",
        "terseLabel": "10-Aug-18 [Member]"
       }
      }
     },
     "localname": "IssueDateFiveMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssueDateFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Date Four Member",
        "terseLabel": "10-May-18 [Member]"
       }
      }
     },
     "localname": "IssueDateFourMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssueDateSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Date Six Member",
        "terseLabel": "21-Mar-19 [Member]"
       }
      }
     },
     "localname": "IssueDateSixMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssueDateThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Date Three Member",
        "terseLabel": "10-Apr-18 [Member]"
       }
      }
     },
     "localname": "IssueDateThreeMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssueDateTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Date Two Member",
        "terseLabel": "5-Dec-17 [Member]"
       }
      }
     },
     "localname": "IssueDateTwoMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_IssuedAndOutstandingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued and outstanding percentage.",
        "label": "Issued And Outstanding Percentage",
        "terseLabel": "Issued and outstanding percentage"
       }
      }
     },
     "localname": "IssuedAndOutstandingPercentage",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHAREBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "tmdi_ItemsThatWereClassifiedToNetLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Items That Were Classified To Net Loss Abstract",
        "terseLabel": "Items that were classified to net loss:"
       }
      }
     },
     "localname": "ItemsThatWereClassifiedToNetLossAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_January2021EquityOfferingNetOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of equity offering, net of issuance costs.",
        "label": "January2021 Equity Offering Net Of Issuance Costs",
        "terseLabel": "January 2021 Equity Offering, net of issuance costs"
       }
      }
     },
     "localname": "January2021EquityOfferingNetOfIssuanceCosts",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_January2021EquityOfferingNetOfIssuanceCostsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2021 Equity Offering, net of issuance costs, shares.",
        "label": "January2021 Equity Offering Net Of Issuance Costs Shares",
        "terseLabel": "January 2021 equity offering, net of issuance costs (in Shares)"
       }
      }
     },
     "localname": "January2021EquityOfferingNetOfIssuanceCostsShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_January2021EquityOfferingNetOfIssuanceCostsvalue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2021 equity offering, net of issuance costs.",
        "label": "January2021 Equity Offering Net Of Issuance Costsvalue",
        "terseLabel": "January 2021 equity offering, net of issuance costs"
       }
      }
     },
     "localname": "January2021EquityOfferingNetOfIssuanceCostsvalue",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_January2021EquityOfferingbrokerWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2021 equity offering-broker warrants.",
        "label": "January2021 Equity Offeringbroker Warrants",
        "terseLabel": "January 2021 equity offering, broker warrants"
       }
      }
     },
     "localname": "January2021EquityOfferingbrokerWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_LeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease term.",
        "label": "Lease Term",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LeaseTerm",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/RIGHTOFUSEASSETSANDLEASELIABILITIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "tmdi_MedtronicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medtronic Member",
        "terseLabel": "Medtronic [Member]"
       }
      }
     },
     "localname": "MedtronicMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_NoncashNotePayableExpensesAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash note payable expenses and accrued liabilities.",
        "label": "Noncash Note Payable Expenses And Accrued Liabilities",
        "terseLabel": "Accrued interest on Note payable"
       }
      }
     },
     "localname": "NoncashNotePayableExpensesAndAccruedLiabilities",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_NumberIssuedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued.",
        "label": "Number Issued Shares",
        "terseLabel": "Number Issued"
       }
      }
     },
     "localname": "NumberIssuedShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) cancelled in a share-based payment arrangement.",
        "label": "Number Of Other Equity Instruments Cancelled In Sharebased Payment Arrangement",
        "terseLabel": "Cancelled"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedrestrictedshareunitsTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "tmdi_NumberOfOtherEquityInstrumentsReleasedInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) released in a share-based payment arrangement.",
        "label": "Number Of Other Equity Instruments Released In Sharebased Payment Arrangement",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsReleasedInSharebasedPaymentArrangement",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofgrantedrestrictedshareunitsTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "tmdi_NumberOfOutstandingWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of warrants outstanding during the period.",
        "label": "Number Of Outstanding Warrants",
        "terseLabel": "Number Outstanding"
       }
      }
     },
     "localname": "NumberOfOutstandingWarrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants issued.",
        "label": "Number Of Warrants Issued",
        "terseLabel": "Number Issued"
       }
      }
     },
     "localname": "NumberOfWarrantsIssued",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumberOfWarrantsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Warrants Outstanding",
        "label": "Number Of Warrants Outstanding",
        "periodEndLabel": "Number of Warrants Outstanding, Ending",
        "periodStartLabel": "Number of Warrants Outstanding, Beginning"
       }
      }
     },
     "localname": "NumberOfWarrantsOutstanding",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumberOfWarrantsOutstandingChangeInFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Warrants Outstanding, Change in fair value.",
        "label": "Number Of Warrants Outstanding Change In Fair Value",
        "terseLabel": "Number of Warrants Outstanding, Change in fair value"
       }
      }
     },
     "localname": "NumberOfWarrantsOutstandingChangeInFairValue",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumberOfWarrantsOutstandingExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of warrants outstanding exercised.",
        "label": "Number Of Warrants Outstanding Exercised",
        "terseLabel": "Number of Warrants Outstanding, Exercised"
       }
      }
     },
     "localname": "NumberOfWarrantsOutstandingExercised",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumberOfWarrantsOutstandingExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of warrants outstanding expired.",
        "label": "Number Of Warrants Outstanding Expired",
        "terseLabel": "Number of Warrants Outstanding, Expired"
       }
      }
     },
     "localname": "NumberOfWarrantsOutstandingExpired",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofwarrantderivativeTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumberOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of outstanding shares.",
        "label": "Number Outstanding Shares",
        "terseLabel": "Number Outstanding"
       }
      }
     },
     "localname": "NumberOutstandingShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofEquityWarrantsWereOutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator Abstract",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_OptionsExercisedDuringQuarterShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options exercised during the quarter, shares.",
        "label": "Options Exercised During Quarter Shares",
        "terseLabel": "Stock options exercised (in Shares)"
       }
      }
     },
     "localname": "OptionsExercisedDuringQuarterShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_OtherExpensesIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses Income Abstract",
        "terseLabel": "Other Expenses (Income)"
       }
      }
     },
     "localname": "OtherExpensesIncomeAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_PercentageOfSharebasedCompensationAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of share-based compensation available for issuance.",
        "label": "Percentage Of Sharebased Compensation Available For Issuance",
        "terseLabel": "Percentage of share-based compensation available for issuance"
       }
      }
     },
     "localname": "PercentageOfSharebasedCompensationAvailableForIssuance",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable_Parentheticals"
     ],
     "xbrltype": "percentItemType"
    },
    "tmdi_ProceedsFromNoncurrentPayables": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from non-current payables.",
        "label": "Proceeds From Noncurrent Payables",
        "terseLabel": "Note payable"
       }
      }
     },
     "localname": "ProceedsFromNoncurrentPayables",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_PurchaseOfCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchase of common stock.",
        "label": "Purchase Of Common Stock",
        "terseLabel": "Purchase of common stock (in Dollars)"
       }
      }
     },
     "localname": "PurchaseOfCommonStock",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_RDStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RDStock Options Member",
        "terseLabel": "Stock options [Member]"
       }
      }
     },
     "localname": "RDStockOptionsMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_RSUsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSUs exercised.",
        "label": "RSUs Exercised",
        "terseLabel": "RSUs exercised"
       }
      }
     },
     "localname": "RSUsExercised",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_RSUsExercisedinShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of restricted stock units exercised.",
        "label": "RSUs Exercisedin Shares",
        "terseLabel": "RSUs exercised (in Shares)"
       }
      }
     },
     "localname": "RSUsExercisedinShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_RSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSUs Member",
        "terseLabel": "RSUs [Member]"
       }
      }
     },
     "localname": "RSUsMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_RSUsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of restricted stock units.",
        "label": "RSUs Shares",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RSUsShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_RSUssMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSUss Member",
        "terseLabel": "RSUs [Member]"
       }
      }
     },
     "localname": "RSUssMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_RepaymentsOfLeaseliabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of lease liabilities.",
        "label": "Repayments Of Leaseliabilities",
        "negatedLabel": "Repayments"
       }
      }
     },
     "localname": "RepaymentsOfLeaseliabilities",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_ResearchAndDevelopmentDepreciation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development depreciation.",
        "label": "Research And Development Depreciation",
        "terseLabel": "R&amp;D - Depreciation"
       }
      }
     },
     "localname": "ResearchAndDevelopmentDepreciation",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ScheduleofdepreciationandamortizationexpenseTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_RetainedEarningAccumulatedDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earning Accumulated Deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningAccumulatedDeficit",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/NATUREOFBUSINESSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_RevisionToIBR": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of revision to IBR.",
        "label": "Revision To IBR",
        "negatedLabel": "Revision to IBR"
       }
      }
     },
     "localname": "RevisionToIBR",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_RevisionToIBRLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of revisions to IBR liabilities.",
        "label": "Revision To IBRLiabilities",
        "negatedLabel": "Revision to IBR"
       }
      }
     },
     "localname": "RevisionToIBRLiabilities",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofrightofuseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans [Line Items]"
       }
      }
     },
     "localname": "SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansLineItems",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansParentheticalsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans (Parentheticals) [Line Items]"
       }
      }
     },
     "localname": "SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansParentheticalsLineItems",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansParentheticalsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans (Parentheticals) [Table]"
       }
      }
     },
     "localname": "SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansParentheticalsTable",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION (Details) - Summary of share-based compensation plans [Table]"
       }
      }
     },
     "localname": "SHAREBASEDCOMPENSATIONDetailsSummaryofsharebasedcompensationplansTable",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_SHAREBASEDCOMPENSATIONDetailsSummaryofstockbasedcompensationexpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION (Details) - Summary of stock-based compensation expense [Line Items]"
       }
      }
     },
     "localname": "SHAREBASEDCOMPENSATIONDetailsSummaryofstockbasedcompensationexpenseLineItems",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_SHAREBASEDCOMPENSATIONDetailsSummaryofstockbasedcompensationexpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE-BASED COMPENSATION (Details) - Summary of stock-based compensation expense [Table]"
       }
      }
     },
     "localname": "SHAREBASEDCOMPENSATIONDetailsSummaryofstockbasedcompensationexpenseTable",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_SHARECAPITALDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE CAPITAL (Details) [Line Items]"
       }
      }
     },
     "localname": "SHARECAPITALDetailsLineItems",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_SHARECAPITALDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE CAPITAL (Details) [Table]"
       }
      }
     },
     "localname": "SHARECAPITALDetailsTable",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_ScheduleOfDepreciationAndAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of depreciation and amortisation expense [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfDepreciationAndAmortizationExpenseAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_ShareBasedCompensationAvailableForFutureGrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation available for future grants.",
        "label": "Share Based Compensation Available For Future Grants",
        "terseLabel": "Common shares reserved for future grants"
       }
      }
     },
     "localname": "ShareBasedCompensationAvailableForFutureGrants",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_ShareBasedCompensationAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation available for issuance.",
        "label": "Share Based Compensation Available For Issuance",
        "terseLabel": "Common shares reserved for issuance: 15%"
       }
      }
     },
     "localname": "ShareBasedCompensationAvailableForIssuance",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_ShareCapitalDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share capital description.",
        "label": "Share Capital Description",
        "terseLabel": "Share capital description"
       }
      }
     },
     "localname": "ShareCapitalDescription",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_StockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of stock options.",
        "label": "Stock Options",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "StockOptions",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_StockOptionsAndRSUToEligibleEmployeesOfficersDirectorsAndExternalConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options And RSUTo Eligible Employees Officers Directors And External Consultants Member",
        "terseLabel": "Stock options and RSU to eligible Employees, Officers, Directors and external consultants [Member]"
       }
      }
     },
     "localname": "StockOptionsAndRSUToEligibleEmployeesOfficersDirectorsAndExternalConsultantsMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable",
      "http://www.titanmedicalinc.com/role/SummaryofsharebasedcompensationplansTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_StockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Member",
        "terseLabel": "Stock options [Member]"
       }
      }
     },
     "localname": "StockOptionsMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_SummaryOfBasicAndFullyDilutedNumberOfSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Basic And Fully Diluted Number Of Shares Abstract"
       }
      }
     },
     "localname": "SummaryOfBasicAndFullyDilutedNumberOfSharesAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfDerivativeWarrantsOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Derivative Warrants Outstanding Abstract"
       }
      }
     },
     "localname": "SummaryOfDerivativeWarrantsOutstandingAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfEquityWarrantsWereOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Equity Warrants Were Outstanding Abstract"
       }
      }
     },
     "localname": "SummaryOfEquityWarrantsWereOutstandingAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfGrantedRestrictedShareUnitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Granted Restricted Share Units Abstract"
       }
      }
     },
     "localname": "SummaryOfGrantedRestrictedShareUnitsAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfGrantedStockOptionsToAcquireCommonStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Granted Stock Options To Acquire Common Stock Abstract"
       }
      }
     },
     "localname": "SummaryOfGrantedStockOptionsToAcquireCommonStockAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfRightOfUseAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Right Of Use Assets Abstract"
       }
      }
     },
     "localname": "SummaryOfRightOfUseAssetsAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfRightOfUseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Right Of Use Liabilities Abstract"
       }
      }
     },
     "localname": "SummaryOfRightOfUseLiabilitiesAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfShareBasedCompensationPlansAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Share Based Compensation Plans Abstract"
       }
      }
     },
     "localname": "SummaryOfShareBasedCompensationPlansAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfStockBasedCompensationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Stock Based Compensation Expense Abstract"
       }
      }
     },
     "localname": "SummaryOfStockBasedCompensationExpenseAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_SummaryOfWarrantDerivativeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Warrant Derivative Abstract"
       }
      }
     },
     "localname": "SummaryOfWarrantDerivativeAbstract",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "xbrltype": "stringItemType"
    },
    "tmdi_TotalCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Total Commitment",
        "terseLabel": "Total commitment"
       }
      }
     },
     "localname": "TotalCommitment",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/DEFERREDREVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_TotalNumberOfSharesDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares diluted.",
        "label": "Total Number Of Shares Diluted",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "TotalNumberOfSharesDiluted",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_TotalRDStockOptionsRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total RDStock Options RSUs Member",
        "terseLabel": "Total R&amp;D - Stock options &amp; RSUs [Member]"
       }
      }
     },
     "localname": "TotalRDStockOptionsRSUsMember",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofstockbasedcompensationexpenseTable"
     ],
     "xbrltype": "domainItemType"
    },
    "tmdi_WARRANTDERIVATIVELIABILITYDetailsSummaryofderivativewarrantsoutstandingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WARRANT DERIVATIVE LIABILITY (Details) - Summary of derivative warrants outstanding [Line Items]"
       }
      }
     },
     "localname": "WARRANTDERIVATIVELIABILITYDetailsSummaryofderivativewarrantsoutstandingLineItems",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_WARRANTDERIVATIVELIABILITYDetailsSummaryofderivativewarrantsoutstandingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WARRANT DERIVATIVE LIABILITY (Details) - Summary of derivative warrants outstanding [Table]"
       }
      }
     },
     "localname": "WARRANTDERIVATIVELIABILITYDetailsSummaryofderivativewarrantsoutstandingTable",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofderivativewarrantsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "tmdi_WarrantLiabilityforeignExchangeAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of warrant liability-foreign exchange adjustment.",
        "label": "Warrant Liabilityforeign Exchange Adjustment",
        "terseLabel": "Warrant liability-foreign exchange adjustment"
       }
      }
     },
     "localname": "WarrantLiabilityforeignExchangeAdjustment",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "tmdi_WarrantsDerivatives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative warrants.",
        "label": "Warrants Derivatives",
        "terseLabel": "Warrants Derivative"
       }
      }
     },
     "localname": "WarrantsDerivatives",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_WarrantsEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of warrants equity shares.",
        "label": "Warrants Equity Shares",
        "terseLabel": "Warrants Equity"
       }
      }
     },
     "localname": "WarrantsEquityShares",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/SummaryofbasicandfullydilutednumberofsharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "tmdi_WarrantsReserve": {
     "auth_ref": [],
     "calculation": {
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A component of equity representing the warrant reserves.",
        "label": "Warrants Reserve",
        "terseLabel": "Contributed surplus \u2013 warrant reserve"
       }
      }
     },
     "localname": "WarrantsReserve",
     "nsuri": "http://www.titanmedicalinc.com/20220930",
     "presentation": [
      "http://www.titanmedicalinc.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r1": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r10": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r100": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r101": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r102": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r103": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r104": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r105": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r106": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r107": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r108": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r109": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r11": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r110": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r111": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r112": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r12": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r13": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r14": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r15": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r16": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r17": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r18": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r19": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r2": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r20": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r21": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r22": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r23": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r24": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r25": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r26": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r27": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r28": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r29": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r3": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r30": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r31": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r32": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r33": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r34": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r35": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r36": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r37": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r38": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r39": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r4": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r40": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r41": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r42": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r43": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r44": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r45": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r46": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2021-03-24"
  },
  "r47": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r48": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r49": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r5": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r50": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r51": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r52": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r53": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r54": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r55": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r56": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r57": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r58": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r59": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r6": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r60": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r61": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r62": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r63": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r64": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r65": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r66": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r67": {
   "Clause": "ix",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r68": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r69": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r7": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r70": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r71": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r72": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r73": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r74": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r75": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r76": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r77": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r78": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r79": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r8": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r80": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r81": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "C12",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C",
   "URIDate": "2021-03-24"
  },
  "r82": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2021-03-24"
  },
  "r83": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Presentation",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2021-03-24"
  },
  "r84": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "44",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r85": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r86": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r87": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r88": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r89": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r9": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r90": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r91": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r92": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r93": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r94": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r95": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r96": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r97": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r98": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r99": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2021-03-24"
  }
 },
 "version": "2.1"
}
